Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):600–604. doi: 10.1158/1055-9965.EPI-09-0861

Table 1.

Distribution of demographic and clinicopathologic characteristics for 15,342 OCAC non-Hispanic Caucasian subjects

Variable Cases (n = 6,965) Controls (n = 8,377)
Age (y), mean (SD) 55.6 (11.8) 55.9 (11.1)
Age group (y), n (%)
 <40 642 (9.2) 586 (7.0)
 40–49 1,422 (20.4) 1,969 (23.5)
 50–59 2,182 (31.3) 2,459 (29.4)
 60–69 1,872 (26.9) 2,284 (27.3)
 >70 847 (12.2) 1,079 (12.8)
Site, n (%)
 AUS 930 (13.4) 1,064 (12.7)
 DOV 620 (8.9) 617 (7.4)
 GER 251 (3.6) 428 (5.1)
 HAW 90 (1.3) 158 (1.9)
 HOP 307 (4.4) 594 (7.1)
 MAL 440 (6.3) 794 (9.5)
 NCO 250 (3.6) 202 (2.4)
 NEC 982 (14.1) 1,050 (12.5)
 POL 275 (3.9) 597 (7.1)
 SEA 1,092 (15.7) 1,213 (14.5)
 STA 369 (5.3) 181 (2.2)
 UCI 404 (5.8) 418 (5.0)
 UKO 467 (6.7) 564 (6.7)
 USC 488 (7.0) 497 (5.9)
Histology
 Serous 3,718 (53.5)
 Mucinous 919 (13.2)
 Endometroid 906 (13.1)
 Clear cell 489 (7.0)
 Mixed cell 158 (2.3)
 Other 755 (10.9)
Behavior
 Borderline/LMP 1,237 (17.8)
 Invasive 5,520 (79.2)
 Unknown 208 (3.0)

Abbreviation: LMP, low malignant potential.